Why CRISPR Therapeutics Stock Fell 15.9% Last Month and Continues to Fall
CRISPR Therapeutics (NASDAQ: CRSP) stock sank by 15.9% in January, according to data from S&P Global Market Intelligence, amid a surge of bearish momentum impacting the broader market.
Source Fool.com